Gene · 6012
Papers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aminoacyl-tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies. | J Inherit Metab Dis | 2026 | 42028791 | PubTator, text mining | PubMed |
| Anti-polymyositis/scleroderma antibody-positive myositis exhibits greater cutaneous T cell activation than anti-ARS antibody-positive myositis. | JAAD Int | 2026 | 41969295 | PubTator, text mining | PubMed |
| OGT mediates O-GlcNAcylation of MEIS2 and affects palatal osteogenic development. | Int J Oral Sci | 2026 | 41936590 | PubTator, text mining | PubMed |
| Unraveling the arsenite response mechanisms in the facultative anaerobe Aromatoleum sp. CIB. | Microbiol Res | 2026 | 41936227 | PubTator, text mining | PubMed |
| Nonlinear stiffness of NompC gating spring and its implication in mechanotransduction. | Sci Adv | 2026 | 41921004 | PubTator, text mining | PubMed |
| M2 Macrophages derived exosomes promoted Periodontal ligament stem cells osteogenic differentiation through secreting CCL18. | Clinics (Sao Paulo) | 2026 | 41903417 | PubTator, text mining | PubMed |
| Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis. | PLoS One | 2026 | 41894423 | PubTator, text mining | PubMed |
| In Vitro Assessment of Osteogenic Modulation and Molecular Responses Induced by Contemporary Endodontic Sealers in MC3T3-E1 Pre-Osteoblasts. | Dent J (Basel) | 2026 | 41892768 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals AR as a potential prognostic factor and immune-related therapeutic target in gastric cancer. | Biochem Biophys Rep | 2026 | 41890218 | PubTator, text mining | PubMed |
| A Multidisciplinary Approach to the Diagnosis and Management of a Mammary Myofibroblastoma in a Male with a History of Diffuse Large B-Cell Lymphoma: A Case Report. | Hematol Rep | 2026 | 41874106 | PubTator, text mining | PubMed |
| Pre-treatment serum albumin predicts relapse in idiopathic inflammatory myopathies: a retrospective cohort study with cytokine profiling. | Rheumatol Adv Pract | 2026 | 41873252 | PubTator, text mining | PubMed |
| Prevalence of antisynthetase antibodies in a multicentre early rheumatoid arthritis cohort. | Acta Clin Belg | 2026 | 41841450 | PubTator, text mining | PubMed |
| Exploring sex bias in cardiometabolic diseases. | Lipids Health Dis | 2026 | 41840637 | PubTator, text mining | PubMed |
| Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and Spain. | Hum Vaccin Immunother | 2026 | 41837957 | PubTator, text mining | PubMed |
| LncRNA GAS5 regulates osteogenic differentiation of human periodontal ligament stem cells through miR-23b-3p/STAT5B axis. | Biochem Biophys Rep | 2026 | 41810089 | PubTator, text mining | PubMed |
Anti-PM/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity. | Cureus | 2026 | 41809306 | PubTator, text mining | PubMed |
| Biomedical titanium-tantalum alloys for orthopedic implant applications: From manufacturing to biological performance. | Bioact Mater | 2026 | 41809098 | PubTator, text mining | PubMed |
| Hypereosinophilia Associated With Antisynthetase Syndrome With Anti-Ro52/PL12 Co-Positivity: An Unusual Presentation. | Clin Case Rep | 2026 | 41788865 | PubTator, text mining | PubMed |
| Visible-light-triggered BMP-2 release from enzymatically crosslinked marine collagen-alginate hydrogel blends enhances osteogenesis in dental pulp stem cells. | Front Physiol | 2026 | 41783803 | PubTator, text mining | PubMed |
| Evaluating the Diagnostic Potential of Myxovirus Resistance Protein 1 (MX1) and Myxovirus Resistance Protein 2 (MX2) As Biomarkers in Idiopathic Inflammatory Myopathies. | Cureus | 2026 | 41769532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6012/papers?page=2